These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 16018876

  • 41. Alternative splicing as a mechanism for regulating 14-3-3 binding: interactions between hD53 (TPD52L1) and 14-3-3 proteins.
    Boutros R, Bailey AM, Wilson SH, Byrne JA.
    J Mol Biol; 2003 Sep 19; 332(3):675-87. PubMed ID: 12963375
    [Abstract] [Full Text] [Related]

  • 42. Alternative Splicing: Expanding the Landscape of Cancer Biomarkers and Therapeutics.
    Bessa C, Matos P, Jordan P, Gonçalves V.
    Int J Mol Sci; 2020 Nov 27; 21(23):. PubMed ID: 33261131
    [Abstract] [Full Text] [Related]

  • 43. Alternative splicing and cancer: a systematic review.
    Zhang Y, Qian J, Gu C, Yang Y.
    Signal Transduct Target Ther; 2021 Feb 24; 6(1):78. PubMed ID: 33623018
    [Abstract] [Full Text] [Related]

  • 44. Allele-specific alternative splicing and its functional genetic variants in human tissues.
    Amoah K, Hsiao YE, Bahn JH, Sun Y, Burghard C, Tan BX, Yang EW, Xiao X.
    Genome Res; 2021 Mar 24; 31(3):359-371. PubMed ID: 33452016
    [Abstract] [Full Text] [Related]

  • 45. Neuron-specific alternative splicing of transcriptional machineries: Implications for neurodevelopmental disorders.
    Porter RS, Jaamour F, Iwase S.
    Mol Cell Neurosci; 2018 Mar 24; 87():35-45. PubMed ID: 29254826
    [Abstract] [Full Text] [Related]

  • 46. Entropy measures quantify global splicing disorders in cancer.
    Ritchie W, Granjeaud S, Puthier D, Gautheret D.
    PLoS Comput Biol; 2008 Mar 14; 4(3):e1000011. PubMed ID: 18369415
    [Abstract] [Full Text] [Related]

  • 47. Differential expression of ARID3B in normal adult tissue and carcinomas.
    Samyesudhas SJ, Roy L, Cowden Dahl KD.
    Gene; 2014 Jun 10; 543(1):174-80. PubMed ID: 24704276
    [Abstract] [Full Text] [Related]

  • 48. An analysis of cancer-related alternative splicing through a genomics-based approach.
    Xu Q, Lee C.
    Discov Med; 2003 Oct 10; 3(18):50-1. PubMed ID: 20704866
    [Abstract] [Full Text] [Related]

  • 49. Transcriptome-wide identification and study of cancer-specific splicing events across multiple tumors.
    Tsai YS, Dominguez D, Gomez SM, Wang Z.
    Oncotarget; 2015 Mar 30; 6(9):6825-39. PubMed ID: 25749525
    [Abstract] [Full Text] [Related]

  • 50. Cancer-associated regulation of alternative splicing.
    Venables JP, Klinck R, Koh C, Gervais-Bird J, Bramard A, Inkel L, Durand M, Couture S, Froehlich U, Lapointe E, Lucier JF, Thibault P, Rancourt C, Tremblay K, Prinos P, Chabot B, Elela SA.
    Nat Struct Mol Biol; 2009 Jun 30; 16(6):670-6. PubMed ID: 19448617
    [Abstract] [Full Text] [Related]

  • 51. Unbalanced alternative splicing and its significance in cancer.
    Venables JP.
    Bioessays; 2006 Apr 30; 28(4):378-86. PubMed ID: 16547952
    [Abstract] [Full Text] [Related]

  • 52. [Alternative splicing regulation: implications in cancer diagnosis and treatment].
    Martínez-Montiel N, Rosas-Murrieta N, Martínez-Contreras R.
    Med Clin (Barc); 2015 Apr 08; 144(7):317-23. PubMed ID: 24725854
    [Abstract] [Full Text] [Related]

  • 53. Subtype-specific alternative splicing events in breast cancer identified by large-scale data analysis.
    Deguchi Y, Kikutake C, Suyama M.
    Sci Rep; 2024 Jun 19; 14(1):14158. PubMed ID: 38898123
    [Abstract] [Full Text] [Related]

  • 54. Significance of alternative splicing in cancer cells.
    Qi F, Li Y, Yang X, Wu YP, Lin LJ, Liu XM.
    Chin Med J (Engl); 2020 Jan 20; 133(2):221-228. PubMed ID: 31764175
    [Abstract] [Full Text] [Related]

  • 55. High-throughput alternative splicing detection using dually constrained correspondence analysis (DCCA).
    Baty F, Klingbiel D, Zappa F, Brutsche M.
    J Biomed Inform; 2015 Dec 20; 58():175-185. PubMed ID: 26483173
    [Abstract] [Full Text] [Related]

  • 56. OncoSplicing: an updated database for clinically relevant alternative splicing in 33 human cancers.
    Zhang Y, Yao X, Zhou H, Wu X, Tian J, Zeng J, Yan L, Duan C, Liu H, Li H, Chen K, Hu Z, Ye Z, Xu H.
    Nucleic Acids Res; 2022 Jan 07; 50(D1):D1340-D1347. PubMed ID: 34554251
    [Abstract] [Full Text] [Related]

  • 57. Alternative splicing and liver disease.
    Baralle M, Baralle FE.
    Ann Hepatol; 2021 Dec 07; 26():100534. PubMed ID: 34547477
    [Abstract] [Full Text] [Related]

  • 58. Functional consequences of developmentally regulated alternative splicing.
    Kalsotra A, Cooper TA.
    Nat Rev Genet; 2011 Sep 16; 12(10):715-29. PubMed ID: 21921927
    [Abstract] [Full Text] [Related]

  • 59. Advances in Analyzing Virus-Induced Alterations of Host Cell Splicing.
    Ashraf U, Benoit-Pilven C, Lacroix V, Navratil V, Naffakh N.
    Trends Microbiol; 2019 Mar 16; 27(3):268-281. PubMed ID: 30577974
    [Abstract] [Full Text] [Related]

  • 60. Alternative splicing and its impact as a cancer diagnostic marker.
    Kim YJ, Kim HS.
    Genomics Inform; 2012 Jun 16; 10(2):74-80. PubMed ID: 23105933
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.